Interim Management Statement

RNS Number : 6261X
Oryx International Growth Fund Ld
17 February 2012
 



ORYX INTERNATIONAL GROWTH FUND LIMITED

 

INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 31 DECEMBER 2011

 

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 October 2011 to 31 December 2011, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

 

Manager's Review

During the period under review, the FTSE Small Cap TR (£) Index returned -1.26% and the FTSE All-Share TR Index (£) returned +8.39%. Against this, the Fund's net asset value rose by 3.7% to 279p per share. Whilst market conditions remain difficult, the Manager believes that there is the potential for corporate activity to occur in the Fund's quoted portfolio and there remains scope for capital appreciation in the unquoted portfolio.

 

 

Material Transactions

Since 1 October 2011, the Company has purchased for cancellation the following shares:

 

14 December 2011 a total of 584,392 ordinary shares at a gross price of £1.90 per share.

19 December 2011 a total of 5,000 ordinary shares at a gross price of £1.90 per share.

28 December 2011 a total of 5,000 ordinary shares at a gross price of £2.00 per share.

9 February 2012 a total of 53,000 ordinary shares at a gross price of £2.02 per share.

 

Material Events

There were no material events during the quarter ended 31 December 2011.

 

 

Report and Accounts

On 25 November 2011, the Company posted its Interim Report for the six months ended 30 September 2011, to Shareholders.

 

 

Financial Highlights

 

 

31 December 2011

30 September 2011

30 June

2011

31 March 2011

31 December 2010

 

 

 

 

 

 

NAV

£2.79

£2.69

£2.96

£2.72

£2.81

 

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5541

 

1.5579

 

1.6055

 

1.6029

 

1.5657

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 31 December 2011

 


% Net Assets



Gleeson (M.J.) Group Plc

7.00

CVS Group Plc

6.71

Redhall Group Plc

6.47

GTL Resources Plc

6.20

Augean Plc

5.47

Guinness Peat Group Plc

5.39

RPC Group Plc

5.28

Orthoproducts Ltd

5.14

Quatro Group Inc

4.99

BBA Aviation Plc

4.28

Idox Plc

4.28

Eckoh Plc

3.97

Assetco Plc

3.87

Catalyst Media Group Plc

3.51

Bavaria Industriekapital Ag

3.14

Sinclair IS Pharma Plc

3.05

Nastor Inv Ltd Zero Redeem Prefer Shares

2.71

Journey Group Plc

2.53

Bionostics Holdings Ltd

2.49

Celsis AG

2.18




85.33

 

 

The financial information for the quarter ended 31 December 2011 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

 

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUUWPUPPUBM
UK 100

Latest directors dealings